Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the long-term safety of desvenlafaxine succinate
sustained-release (DVS SR) during open-label treatment in adult outpatients with fibromyalgia
syndrome.